|  Nederlands |  English |
 
 
03/07/2002: Prime Minister Guy Verhofstadt lays first stone of new Discovery Research Center in Beerse

Late last year, Janssen started drawing up a preliminary study for two new research buildings in Beerse, a result of the company's tighter focus on forward-looking areas of research. Vigorous investment in new research buildings, namely the Discovery Research Center (DRC) and the Drug Safety Evaluation Center (DSEC), is the logical consequence of that decision.

Early this year, Janssen began preparing for the construction of the larger of the two buildings, the DRC, which will take up a surface area of 16,470 m2.

The laboratories housed in it will meet the strictest requirements and should enable Janssen to attract highly qualified scientists from all over the world. The aim is to have some 285 R&D staff move into the new Discovery Research Center in the spring of 2004.

On July 3, Prime Minister Guy Verhofstadt paid a visit to Beerse to lay the first stone for the project, the most prestigious in the company's history. In his speech he stressed both the importance of investing in drug research for the well-being of all and the role that Janssen Pharmaceutica, Janssen-Cilag and Johnson & Johnson can play in this context.

 
 
 
Press Releases 2002
04/12/2002 Laboratory Technician Day on December 4, 2002 for the Kempen Catholic Technical College of Geel: an opportunity to become acquainted with Janssen Pharmaceutica in Beerse and… perhaps even the key to your future!
11/12/2002 Janssen Pharmaceutica invests another 50 million euros
08/10/2002 Scientists elect Johnson & Johnson as third most attractive employer in the world
20/09/2002 Janssen Pharmaceutica Goes for Public Transportation
10/09/2002 Durogesic reaches a milestone
01/09/2002 Risperdal Consta, a new generation of atypical antipsychotics
04/07/2002 2001 - A very successful year for Janssen Pharmaceutica
03/07/2002 Prime Minister Guy Verhofstadt lays the first stone of the new Discovery Research Center in Beerse
22/05/2002 "Beerse 2" is biggest computer- and telecomcenter for J&J-group in Europe
05/05/2002 Open house at Janssen Pharmaceutica in Geel a success!
18/04/2002 Data suggest Reminyl effectively treats dementia in patients with cerebrovascular disease
15/04/2002 Investing in research: patients are Worth the Risk
12/04/2002 J&J in top 50 Business week
04/04/2002 Janssen Pharmaceutica NV most engaging employer in Belgium
 

 

 
© Janssen Pharmaceutica N.V., 1997-2008.

This site is published by Janssen Pharmaceutica NV and is intended for visitors from Europe. Use of the site constitutes your consent to application of European laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.